Biogen Stock
BIIB Stock: Election Catalyst Biogen Inc (NASDAQ:BIIB) stock has been halved, as the biotech space has been under duress and the selling-pressure catalyst has been the United States presidential election. Both presidential candidates have pledged to crack down on the alleged price gouging that biotech companies have been accused…
Biogen Stock Could Benefit from Bidding War The takeover rumors surrounding Biogen Inc (NASDAQ:BIIB) are not going away; instead, they are getting stronger. It seems it’s not just Merck & Co., Inc. (NYSE:MRK) and Allergan plc (NYSE:AGN) that have shown interest in buying out the company. The combined…